Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.

about

Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.

Item

http://www.wikidata.org/entity/Q55261217

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prediction of clinical outcome ...... and a combined response score.

@en

Prediction of clinical outcome ...... and a combined response score.

@nl

type

Item

label

Prediction of clinical outcome ...... and a combined response score.

@en

Prediction of clinical outcome ...... and a combined response score.

@nl

prefLabel

Prediction of clinical outcome ...... and a combined response score.

@en

Prediction of clinical outcome ...... and a combined response score.

@nl

P1476

Prediction of clinical outcome ...... and a combined response score

@en

P2093

C Reitan

http://www.w3.org/2001/XMLSchema#string

J P Singh

http://www.w3.org/2001/XMLSchema#string

N C Chatterjee

http://www.w3.org/2001/XMLSchema#string

R Borgquist

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death.

Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial.

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.

Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.

Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones

Cardiac resynchronization therapy for heart failure.

P2888

s12872-018-0802-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-018-0802-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Z Bakos

P577

2018-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103660622

http://www.w3.org/2001/XMLSchema#string

P698

29699498

http://www.w3.org/2001/XMLSchema#string

P932

5921413

http://www.w3.org/2001/XMLSchema#string